Publications by authors named "Alanood A Howsawi"
Article Synopsis
- - Glycemic variability (GV) has been identified as a significant predictor of major adverse cardiovascular events (MACE) in patients with type 2 diabetes, showing a particular correlation with fasting blood sugar variability (FBS-CV).
- - In a study of 680 type 2 diabetes patients, MACE events were closely tied to FBS-CV levels, while diabetic microvascular complications (DMC) were more influenced by the duration of diabetes and glycemic control measures.
- - The research indicated that patients on metformin and DPP-4 inhibitors had the lowest glycemic variability compared to those using insulin or sulfonylureas, suggesting that medication choice could play a role in cardiovascular risk management.
